Navigation Links
MAP Pharmaceuticals Reports Second Quarter of 2011 Financial Results
Date:8/4/2011

in neurology.  The Company is developing LEVADEX, an orally inhaled investigational drug for the acute treatment of migraine.  The U.S. Food and Drug Administration has accepted for filing the New Drug Application for LEVADEX for the potential acute treatment of migraine in adults. MAP Pharmaceuticals has entered into a collaboration agreement with Allergan, Inc. to co-promote LEVADEX to neurologists and pain specialists in the U.S. and Canada. The Company also applies its proprietary drug particle and inhalation technologies to generate new pipeline opportunities by enhancing the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

Forward-Looking StatementsIn addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to MAP Pharmaceuticals' LEVADEX product candidate. Actual results may differ materially from current expectations based on risks and uncertainties affecting the Company's business, including, without limitation, risks and uncertainties relating to the regulatory process to have the Company's LEVADEX product candidate approved for commercial use and the commercialization of LEVADEX, if approved. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. Additional information on potential factors that could affect MAP Pharmaceuticals' results and other risks and uncertainties are detailed in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, available at http://edgar.sec.gov.

'/>"/>
SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Vanda Pharmaceuticals Reports Second Quarter 2011 Results
2. Savient Pharmaceuticals Reports Second Quarter 2011 Financial Results
3. Christian S. Schade to Join Omthera Pharmaceuticals as Executive Vice President and Chief Financial Officer
4. Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results
5. Onyx Pharmaceuticals Reports Second Quarter 2011 Financial Results
6. Access Pharmaceuticals Adds Blue Cross Blue Shield of Hawaii, SummaCare and AvMed to MuGard Payer List
7. Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects?
8. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of August 2011
9. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
10. Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society
11. MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA for LEVADEX®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014 Research and ... "Prepackaged Medical Kits and Trays - Global ... http://photos.prnewswire.com/prnh/20130307/600769 ... Prepackaged Medical Kits and Trays in US$ Thousands ... Ophthalmic Custom Trays, Custom Basin Kits, Custom Ob/Gyn ...
(Date:7/23/2014)... 23, 2014 Sinovac Biotech Ltd. (NASDAQ: ... China , announced today that it has been ... ("Beijing CDC") to be a supplier of the seasonal influenza ... for 2014. The Beijing CDC plans to order ... vaccine this year from four domestic vaccine manufacturers for its ...
(Date:7/22/2014)...  Nektar Therapeutics (Nasdaq: NKTR ) will announce ... 2014 on Thursday, July 31, 2014, after the close of ... executive officer, will host a conference call to review the ... Time (PT). The press release and a ... through a link that is posted on the home page ...
Breaking Medicine Technology:Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report 2Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 3
... DeVilbiss Healthcare has selected Business & Decision, following a ... its Microsoft Dynamics AX solution. As ... to select and implement a global solution well suited ... The primary reasons for choosing Dynamics ...
... Compliance Implementation Services (CIS), a pharmaceutical compliance consulting ... to Inc. Magazine,s fourth annual Top 5000 list ... States. (Logo:   http://photos.prnewswire.com/prnh/20100817/INC5000LOGO ) ... leaders of the companies on this year,s Inc. ...
Cached Medicine Technology:Business & Decision North America Announces the Successful Go-Live of Microsoft Dynamics AX at DeVilbiss Healthcare 2Despite Economic Turmoil, CIS Named to Inc. 5000 List of Fastest-Growing Private Companies in America 2
(Date:7/23/2014)... By using brightly hued dyes, George Mason University ... proteins touch each other, possibly leading to new ... lung disease. , George Mason researchers unraveled the ... touch each other. "One protein interlocks with another ... and this sends a signal down the line ...
(Date:7/23/2014)... Boston, MA (PRWEB) July 23, 2014 ... software technologies, the leasing and financing company LeaseQ ... in the server based software sector, they still ... sectors. , To learn more about technology ... Tirey, Founder and CEO of LeaseQ was quoted ...
(Date:7/23/2014)... 23, 2014 Splashtop , ... announce that it has joined the RSA Ready ... Splashtop Enterprise and RSA SecurID® multi-factor authentication solution ... , Splashtop also announced that leading ... deploying Splashtop Enterprise, the industry’s only on-premise remote ...
(Date:7/23/2014)... joined together for the first time to call for ... people worldwide suffering from the condition. , Psoriatic arthritis ... joint damage if left untreated. , PsA tends to ... a red, scaly rash, and affects approximately two per ... one in five go on to develop PsA ...
(Date:7/23/2014)... 2014 On July 21, 2014, My Positive ... Jack Tracey for an episode that spoke about the group ... asks Tracey to talk some about the formation of the ... mission, it was started right here in Charleston, originally it ... to help survivors of sexual abuse. Their purpose has shifted ...
Breaking Medicine News(10 mins):Health News:Researchers unlock the protein puzzle 2Health News:LeaseQ Announces That Although Software Investment Remains Sluggish, Technology Equipment Leasing Demand Remains Robust 2Health News:LeaseQ Announces That Although Software Investment Remains Sluggish, Technology Equipment Leasing Demand Remains Robust 3Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 3Health News:Psoriatic arthritis patients need better screening, warns panel of experts 2Health News:My Positive Perspective Airs Episode to Raise Attention to the Group Darkness to Light 2
... ... voice of the stem cell revolution, is on a 10 city speaking/book tour including Spokane. ... ... interest in the stem cell phenomenon made a science book an overnight Amazon Best Seller ...
... , ... ... ... , ...
... ... ... ... ...
... Ill. -- Loyola University Medical Center ranked among ... research competition for pathologists in training. Loyola was ... of scientific studies accepted in the Stowell-Orbison Awards competition ... Pathology (USCAP). One hundred academic programs worldwide participated in ...
... doors, expert says , FRIDAY, Feb. 19 (HealthDay News) -- ... pediatric amputations due to trauma in the United States in ... found that there were more than 950 cases of traumatic ... children aged 4 and younger, amputations due to being caught ...
... treatments for blindness, researchers say , FRIDAY, Feb. 19 (HealthDay ... to see color than humans, a new study finds. , ... chicken,s eye and found that the receptors are arranged in ... colors in any part of the retina, the light-sensing structure ...
Cached Medicine News:Health News:Health: Surprise Best Seller is Stem Cell Book – Author in Spokane - 10 City Tour 2Health News:WebMD to Present at the Goldman Sachs Technology and Internet Conference 2010 2Health News:WebMD to Present at the Goldman Sachs Technology and Internet Conference 2010 3Health News:Medicare Advantage Members May Make Changes During Open Enrollment 2Health News:Medicare Advantage Members May Make Changes During Open Enrollment 3Health News:Traumatic Amputations in Children Have High Costs 2Health News:Chickens May Provide Clues to Color Vision 2
... Freedom leg bags are part ... a versatile line of leg bags, ... the varied needs of our customers. ... several sizes, and constructed of 100% ...
... are part of the Freedom Urinary ... leg bags, kits, and accessories designed ... our customers. These leg bags are ... of 100% latex-free soft, textured medical ...
... Freedom leg bags are part of ... versatile line of leg bags, kits, ... varied needs of our customers. These ... sizes, and constructed of 100% latex-free ...
... Rochester Medical's line of ... intermittent catheters you would ... four product configurations - ... antibacterial hydro - are ...
Medicine Products: